Blood Advances
-
Publication Venue For
- The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma. 5:1933-1946. 2021
- Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study.. 4:4463-4473. 2020
- Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. 3:3248-3260. 2019
- Erratum: Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs (Blood Advances (2017) 1:25 (2329-2342) DOI: 10.1182/bloodadvances.2017011411). 2:516. 2018
- Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs.. 1:2329-2342. 2017
- Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates.. 1:2115-2119. 2017
- Depression, quality of life, and medical resource utilization in sickle cell disease.. 1:1983-1992. 2017
- IAPs protect host target tissues from graft-versus-host disease in mice.. 1:1517-1532. 2017
- Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions.. 1:1142-1147. 2017
- Serologic characterization of anti-protamine/heparin and anti-PF4/heparin antibodies.. 1:644-651. 2017
- US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALL.. 1:250-259. 2016
- Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.. 1:62-74. 2016
- Should we avoid heparin to eliminate HIT?. 1:4. 2016